James Investment Research Inc Bio N Tech Se Transaction History

James Investment Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$123.25 - $186.24 $17,378 - $26,259	-141 Reduced 89.81%	16 $2,000
Q1 2022 Apr 22, 2022	BUY	$126.25 - $231.85 $1,515 - $2,782	12 Added 8.28%	157 $27,000
Q4 2021 Jan 28, 2022	SELL	$216.64 - $362.52 $4,549 - $7,612	-21 Reduced 12.65%	145 $37,000
Q3 2021 Oct 22, 2021	SELL	$205.93 - $447.23 $205 - $447	-1 Reduced 0.6%	166 $45,000
Q2 2021 Jul 26, 2021	BUY	$113.32 - $241.49 $18,924 - $40,328	167 New	167 $37,000

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.